Search research articles
Contact Us
Filters
Showing results (71-80 of 161) with videos related to
Page
of 17
Sort By:
Cancer
|
October 9, 2009
Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group
Howard M Katzenstein, Kay W Chang, Mark Krailo, et al.
The Journal of Bone and Joint Surgery. American Volume
|
March 4, 2009
Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcoma
Hamayun Imran, Felicity Enders, Mark Krailo, et al.
Pediatric Blood & Cancer
|
May 27, 2023
Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International Consortium
Ana Glenda Santarosa Vieira, Vidya Puthenpura, Mark Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2004
Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study
Victor M Aquino, Steve D Weitman, Naomi J Winick, et al.
Cancer Medicine
|
May 31, 2018
Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials
Lori M Minasian, A Lindsay Frazier, Lillian Sung, et al.
Pediatric Blood & Cancer
|
June 27, 2020
A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231)
Rima F Jubran, Judith G Villablanca, Mark Krailo, et al.
Pediatric Blood & Cancer
|
August 20, 2013
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group
Brenda Weigel, Suman Malempati, Joel M Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience
Anne L Angiolillo, Virginia Davenport, Mary Ann Bonilla, et al.
Pediatric Blood & Cancer
|
May 29, 2008
Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group
Patrick J Leavey, Leo Mascarenhas, Neyssa Marina, et al.
The Journal of Pathology. Clinical Research
|
June 9, 2015
Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group
Samuel L Volchenboum, Jorge Andrade, Lei Huang, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 161) with videos related to
Sort By:
Page
of 17
Cancer
|
October 9, 2009
Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group
Howard M Katzenstein, Kay W Chang, Mark Krailo, et al.
The Journal of Bone and Joint Surgery. American Volume
|
March 4, 2009
Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcoma
Hamayun Imran, Felicity Enders, Mark Krailo, et al.
Pediatric Blood & Cancer
|
May 27, 2023
Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International Consortium
Ana Glenda Santarosa Vieira, Vidya Puthenpura, Mark Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2004
Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study
Victor M Aquino, Steve D Weitman, Naomi J Winick, et al.
Cancer Medicine
|
May 31, 2018
Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials
Lori M Minasian, A Lindsay Frazier, Lillian Sung, et al.
Pediatric Blood & Cancer
|
June 27, 2020
A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231)
Rima F Jubran, Judith G Villablanca, Mark Krailo, et al.
Pediatric Blood & Cancer
|
August 20, 2013
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group
Brenda Weigel, Suman Malempati, Joel M Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience
Anne L Angiolillo, Virginia Davenport, Mary Ann Bonilla, et al.
Pediatric Blood & Cancer
|
May 29, 2008
Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group
Patrick J Leavey, Leo Mascarenhas, Neyssa Marina, et al.
The Journal of Pathology. Clinical Research
|
June 9, 2015
Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group
Samuel L Volchenboum, Jorge Andrade, Lei Huang, et al.
Page
of 17